Hepatic angiosarcoma associated with short-term arsenic ingestion

Area of Science:

• Oncology
• Toxicology
• Pathology

Background:

• Hepatic angiosarcoma is a rare liver cancer.
• Arsenic exposure is a known risk factor for various cancers.
• The latency period between arsenic exposure and cancer development can be long.

Observation:

• A 45-year-old male developed hepatic angiosarcoma 33 years after a 6-month course of medicinal arsenic.
• The patient also had a history of basal cell carcinomas, unrelated to excessive sun exposure.
• Tumor staining for Factor VIII indicated an endothelial cell origin.

Findings:

• The case demonstrates a strong association between past arsenic ingestion and subsequent development of hepatic angiosarcoma.
• The co-occurrence of skin cancers further supports a potential link between arsenic and oncogenesis.
• The long latency period suggests arsenic's persistent carcinogenic effects.

Implications:

• This case challenges the notion of a safe threshold for arsenic exposure.
• Clinicians should inquire about historical arsenic exposure in patients diagnosed with hepatic angiosarcoma.
• Further investigation may reveal more cases linking short-term arsenic exposure to cancer.